MARKET

MENS

MENS

Jyong Biotech Ltd.
NASDAQ
1.470
+0.010
+0.68%
Closed 19:09 02/12 EST
OPEN
1.530
PREV CLOSE
1.460
HIGH
1.844
LOW
1.460
VOLUME
1.03M
TURNOVER
--
52 WEEK HIGH
67.00
52 WEEK LOW
1.430
MARKET CAP
111.76M
P/E (TTM)
-84.4828
1D
5D
1M
3M
1Y
5Y
1D
Jyong Biotech Completes Phase II Trial For MCS-8, Expands Commercial Presence In Asia
Benzinga · 19h ago
Jyong issues strategic corporate update, completes Phase II trial for MCS-8
TipRanks · 19h ago
Jyong Biotech Reports Positive Phase II Results for MCS-8 in Prostate Cancer Prevention and Metabolic Health
Reuters · 19h ago
Weekly Report: what happened at MENS last week (0202-0206)?
Weekly Report · 4d ago
Jyong Biotech Appoints Veteran Capital Markets Executive Wei Zhang as Chief Financial Officer
TipRanks · 6d ago
Jyong Biotech Ltd. Appoints Wei Zhang as Chief Financial Officer
Reuters · 6d ago
Weekly Report: what happened at MENS last week (0126-0130)?
Weekly Report · 02/02 09:05
BUZZ-U.S. STOCKS ON THE MOVE-Church & Dwight, Tesla, Oppenheimer
Reuters · 01/30 18:38
More
About MENS
Jyong Biotech Ltd is a Taiwan-based science-driven biotechnology company. The Company is mainly engaged in developing and commercializing innovative and differentiated new drugs (plant-derived) mainly specializing in the treatment of urinary system diseases, with an initial focus on the markets of the United States (U.S.), the European Union (EU), and Asia. The Company has been developing a series of botanical drug candidates, including primary botanical drug candidate of MCS-2, another clinical-stage botanical drug candidate of PCP, and other preclinical-stage botanical drug candidates. MCS-2 is a new botanical drug candidate developed for treatment of benign prostate hyperplasia/lower urinary tract symptoms (BPH/LUTS). PCP is a new botanical drug candidate developed for the prevention of prostate cancer.

Webull offers Jyong Biotech Ltd. stock information, including NASDAQ: MENS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MENS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MENS stock methods without spending real money on the virtual paper trading platform.